6th Cir. Allows Multi-Million Dollar Verdict to Stand in Gadolinium Toxicity Case

CINCINNATI — A federal appeals court has upheld a multi-million dollar verdict issued in a gadolinium toxicity case, finding the trial court did not err in its evidentiary rulings and did not abuse its discretion in denying GE Healthcare’s motion for a new trial.

On Oct. 20, the 6th Circuit U.S. Court of Appeals affirmed the jury’s $4.5 million verdict issued in favor of Paul Decker and the $500,000 award to his wife for loss of consortium.

In September 2005, Decker, a patient with end-stage renal disease, underwent an MRI and received a single dose of Omniscan. He later developed …